69 related articles for article (PubMed ID: 27392988)
1. [Not Available].
Schieveen PG; Hulin A; Muret P; Royer B;
Therapie; 2010; 65(3):207-12. PubMed ID: 27392988
[TBL] [Abstract][Full Text] [Related]
2. [Level of evidence for therapeutic drug monitoring for etoposide after oral administration].
Schieveen PG; Hulin A; Muret P; Royer B;
Therapie; 2010; 65(3):207-12. PubMed ID: 20699072
[TBL] [Abstract][Full Text] [Related]
3. Level of evidence for therapeutic drug monitoring for etoposide after oral administration.
Gerritsen-van Schieveen P; Royer B;
Fundam Clin Pharmacol; 2011 Jun; 25(3):277-82. PubMed ID: 20608987
[TBL] [Abstract][Full Text] [Related]
4. [Not Available].
Muret P; Piedoux S; Solas C; Quaranta S;
Therapie; 2011; 66(3):187-95. PubMed ID: 27393198
[TBL] [Abstract][Full Text] [Related]
5. [Not Available].
Schieveen PG; Royer B;
Therapie; 2011; 66(1):51-5. PubMed ID: 27393465
[TBL] [Abstract][Full Text] [Related]
6. [Not Available].
Schieveen PG; Royer B;
Therapie; 2010; 65(3):195-200. PubMed ID: 27392986
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer.
Yong WP; Desai AA; Innocenti F; Ramirez J; Shepard D; Kobayashi K; House L; Fleming GF; Vogelzang NJ; Schilsky RL; Ratain MJ
Cancer Chemother Pharmacol; 2007 Nov; 60(6):811-9. PubMed ID: 17308893
[TBL] [Abstract][Full Text] [Related]
8. [Not Available].
Muret P; Solas C;
Therapie; 2011; 66(3):207-12. PubMed ID: 27393200
[TBL] [Abstract][Full Text] [Related]
9. [Not Available].
Barrail-Tran A; Taburet AM; Poirier JM;
Therapie; 2011; 66(3):239-46. PubMed ID: 27393204
[TBL] [Abstract][Full Text] [Related]
10. [Not Available].
Solas C; Paré M; Quaranta S; Stanke-Labesque F;
Therapie; 2011; 66(3):221-30. PubMed ID: 27393202
[TBL] [Abstract][Full Text] [Related]
11. [Not Available].
Schieveen PG; Royer B;
Therapie; 2010; 65(3):201-6. PubMed ID: 27392987
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic aspects of oral administration of etoposide].
Tillmann B; Krümpelmann S; Würthwein G; Wagner A; Schulze-Westhoff P; Hempel G; Jürgens H; Boos J
Klin Padiatr; 1998; 210(4):159-64. PubMed ID: 9743946
[TBL] [Abstract][Full Text] [Related]
13. Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study.
Porter D; Boddy A; Thomas H; Lind M; Newell D; Calvert AH; Robson L; Brampton M; Abrahamsen D; Winograd B
Semin Oncol; 1996 Dec; 23(6 Suppl 13):34-44. PubMed ID: 8996574
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of 21-day continuous oral etoposide in pediatric patients with solid tumors.
Sonnichsen DS; Ribeiro RC; Luo X; Mathew P; Relling MV
Clin Pharmacol Ther; 1995 Jul; 58(1):99-107. PubMed ID: 7628187
[TBL] [Abstract][Full Text] [Related]
15. Level of evidence for therapeutic drug monitoring of taxanes.
Gerritsen-van Schieveen P; Royer B;
Fundam Clin Pharmacol; 2011 Aug; 25(4):414-24. PubMed ID: 20840221
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Barrail-Tran A; Taburet AM; Poirier JM;
Therapie; 2011; 66(3):231-8. PubMed ID: 27393203
[TBL] [Abstract][Full Text] [Related]
17. [Not Available].
Charles M; Le Guellec C; Richard D; Libert F;
Therapie; 2011; 66(2):103-8. PubMed ID: 27393644
[TBL] [Abstract][Full Text] [Related]
18. Inter- and intrapatient variability in etoposide kinetics with oral and intravenous drug administration.
Hande K; Messenger M; Wagner J; Krozely M; Kaul S
Clin Cancer Res; 1999 Oct; 5(10):2742-7. PubMed ID: 10537337
[TBL] [Abstract][Full Text] [Related]
19. [Not Available].
Hulin A; Royer B; Chatelut E; Le Guellec C;
Therapie; 2010; 65(3):151-5. PubMed ID: 27392980
[TBL] [Abstract][Full Text] [Related]
20. [Not Available].
Solas C; Muret P;
Therapie; 2011; 66(3):213-9. PubMed ID: 27393201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
